BIOGY (BioGaia AB) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOGY BioGaia AB BIOGY
99 GF Score
Price $12.45
GF Value $11.90
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is BioGaia AB Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioGaia AB  (OTCPK:BIOGY) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


BioGaia AB Cyclically Adjusted PB Ratio Related Terms


BioGaia AB Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for BioGaia AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB Cyclically Adjusted PB Ratio Chart

BioGaia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.08 7.01 7.03 6.68 7.01

BioGaia AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.40 7.95 7.68 7.58 7.32

BIOGY vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Cyclically Adjusted PB Ratio falls into.


BIOGY
99GF Score
BioGaia AB BIOGY
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioGaia AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

BioGaia AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, BioGaia AB's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.155/134.6100*134.6100
=1.155

Current CPI (Jun. 2026) = 134.6100.

BioGaia AB Quarterly Data

Book Value per Share CPI Adj_Book
201609 0.520 101.138 0.692
201612 0.551 102.022 0.727
201703 0.618 102.022 0.815
201706 0.537 102.752 0.703
201709 0.617 103.279 0.804
201712 0.683 103.793 0.886
201803 0.729 103.962 0.944
201806 0.576 104.875 0.739
201809 0.611 105.679 0.778
201812 0.691 105.912 0.878
201903 0.706 105.886 0.898
201906 0.541 106.742 0.682
201909 0.558 107.214 0.701
201912 0.654 107.766 0.817
202003 0.665 106.563 0.840
202006 0.721 107.498 0.903
202009 0.778 107.635 0.973
202012 2.186 108.296 2.717
202103 2.120 108.360 2.634
202106 2.146 108.928 2.652
202109 2.161 110.338 2.636
202112 2.132 112.486 2.551
202203 2.158 114.825 2.530
202206 1.752 118.384 1.992
202209 1.713 122.296 1.885
202212 1.946 126.365 2.073
202303 2.069 127.042 2.192
202306 1.793 129.407 1.865
202309 1.878 130.224 1.941
202312 2.071 131.912 2.113
202403 2.084 132.205 2.122
202406 1.529 132.716 1.551
202409 1.640 132.304 1.669
202412 1.601 132.987 1.621
202503 1.817 132.825 1.841
202506 1.243 133.699 1.251
202509 1.329 133.480 1.340
202512 1.447 133.380 1.460
202603 1.495 133.550 1.507
202606 1.155 134.610 1.155

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is BioGaia AB (BIOGY) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be overvalued. The current stock price of $12.45 is trading 4.6% above its estimated GF Value™ of $11.90. GuruFocus considers BioGaia AB to be Fairly Valued.

Key valuation signals for BIOGY:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $11.90 vs. price of $12.45 (4.6% above fair value)
  • GF Score™: 99/100 with 1 warning sign

No single metric tells the full story. See the BIOGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioGaia AB Business Description

Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
99GF Score

Get the complete analysis for BIOGY

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.45
Price
$11.90
GF Value